.Novo Nordisk is actually proceeding its own push right into hereditary medicines, accepting to pay ...
.Innovent Biologics has actually produced the situation that its own checkpoint inhibitor-cytokine c...
.A phase 3 trial of Daiichi Sankyo and Merck & Co.'s HER3-directed antibody-drug conjugate (ADC) ...
.5 months after Rakovina Rehabs turned towards artificial intelligence, the cancer-focused biotech h...
.Ascendis Pharma has emerged as a prospective risk to BioMarin's Voxzogo, disclosing period 3 develo...
.Though Alkeus Pharmaceuticals' dental eye condition property stopped working to dramatically lessen...
.Along with a triad of biotechs attacking the Nasdaq on Friday, it was simple to miss out on a small...
.Invulnerable gate inhibitors are the superheroes of cancer cells therapy. Medicines like Bristol My...
.Welcome to recently's Chutes & Ladders, our roundup of significant leadership hirings, shootings...
.Regeneron is back with long-term follow-up for its LAG-3 prevention as well as PD-1 prevention comb...